Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy
Condition(s):Geographic AtrophyLast Updated:November 10, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Geographic AtrophyLast Updated:November 10, 2021Completed
Condition(s):Age Related Macular Degeneration; Geographic AtrophyLast Updated:January 20, 2014Completed
Condition(s):Geographic Atrophy; Age-related Macular DegenerationLast Updated:September 18, 2019Completed
Condition(s):Macular DegenerationLast Updated:August 21, 2018Completed
Condition(s):Age-Related Macular Degeneration; Geographic Atrophy; Reticular PseudodrusenLast Updated:February 17, 2020Completed
Condition(s):Geographic Atrophy; Dry Age Related Macular DegenerationLast Updated:June 22, 2010Completed
Condition(s):Geographic AtrophyLast Updated:October 6, 2020Completed
Condition(s):Geographic Atrophy; Age Related Macular DegenerationLast Updated:August 13, 2019Withdrawn
Condition(s):Geographic Atrophy; Age-Related Macular DegenerationLast Updated:July 3, 2014Terminated
Condition(s):Age Related Macular DegenerationLast Updated:December 14, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.